About Technology Transfer Agents

There are no direct financial fruits of one patent to possess. There are a number of patents and products that are unnecessary, are in the state-funded universities and research laboratories across the country. A license or product may be adopted, purchased or leased by a company for development. The technology transfer agents are available for the cycle of innovation by the market closes, products and services that are funded by federal research institutes. They have also been catalysts for innovation. The only reason a transfer agent, has funded research available to the private sector to explore new applications for new inventions, technologies and products. To return royalties and revenues to the research organization. More than 700 laboratories and research institutions to apply their research capabilities and expertise for developing and promoting science and nearly all ministries and agencies to make more than $ 100 U.S. dollars in research and development per year and employ over 100,000 scientists. Their science makes our lives safer, more convenient and medical transportation to the performance of the communication of this research study all that is known and to extract knowledge from the unknown to this day. These efforts of scientists, desires and creativity is unparalleled. But all this work is for nothing if the talents of a genius is not released. It is really mind blowing necessary changes happening behind the laboratory doors are transferred logical existence of practical existence. For all the benefits of federal investment in national research, if the expertise and technology on the market that not only increases the security of the country and the socio-economic well-being in the world market, but also marketed guaranteed. This transfer is done by the excellent work of scientists, representatives of the Agency, and technology transfer professionals. This achievement requires a vision, a plan and methodology. In 2003 LipidLabs acquired and markets advanced technology control lipoprotein fingerprints, allowing doctors to better identify the risks to health. After the technology matures, it has been sold Spectracell Laboratories, Inc. for $ 354,000 and retained a royalty, which are then distributed to the best of shareholders as dividends. Drawing on the strength of the success to continue to capitalize on lipids, stay awake and deliver the next generation of technology R & D institutions such as Texas A & M on the market. LipidLabs, Inc., in partnership with Fortune 500 companies, small businesses, universities and research innovations on the market. Find or financing of private participation and public LipidLabs turn research into reality. LipidLabs has the vision, planning and methodology with tools and services to ensure that the efforts of engineers and scientists from the federal government is not left on a shelf. LipidLabs developed and tested delivery methods, addresses barriers to the process, facilitates the process of marketing and provides additional funding for product development required. LipidLabs provides funding, private funding, and accelerate commercialization. Three segments of the commercialization of R & D are the basis for services LipidLabs Technology Transfer: 1) Nano-technology and materials applied research, 2) bimolecular sciences, wellness and health, and 3 ) manufacturing, transportation and storage. In most cases, LipidLabs receive an exclusive license and marketing rights to the university or research institution, payment of royalties to the University of the profits generated by this technique will allow. In some cases LipidLabs actually buys patents on the products in development. LipidLabs growth strategy is the first strategy is to simply increase the number and value of technology reviews. The second strategy is to broaden the customer and the supplier of the University. LipidLabs should continue to develop new technologies and the use of millions of dollars in research grants for universities to devote to the development of these products.